Pure Global
PACTR201510001292136

Comparative study of Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade

Comparative study of Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in patients undergoing bronchoscopic lung biopsy
shahira el metainy·Not Applicable·Pan Africa Clinical Trials Registry·drugNot yet recruiting
Study focus
Disease/Condition
Respiratory; Other
Intervention type
drug
Sponsor & location
Primary sponsor
shahira el metainy
Funder
el Faculty of Medicine, University of Alexandria, Egypt
Location
Egypt
Timeline & enrollment
Phase
Not Applicable
Start date
Mar 09, 2016
End date
Jan 01, 1900
Summary

Postoperative residual paralysis remains a common occurrence following the use of neuromuscular blocking agents (NMBAs), Rapid and complete reversal of neuromuscular blockade (NMB) is desirable at the end of surgery. Sugammadex reverses rocuronium-induced NMB by encapsulation. Prompt recovery of laryngeal reflexes and spontaneous respiration at the end of the interventional bronchoscopy procedures prevent adverse respiratory eventsAim of the workThe aim of this study was to compare the efficacy of sugammadex and neostigmine on reversing neuromuscular blockade in elderly patients undergoing lung biopsy

ICD-10 classifications
Other specified respiratory disordersOther respiratory disordersOther diseases of the respiratory systemOther postprocedural respiratory disordersOther respiratory conditions due to chemicals, gases, fumes and vapours
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR201510001292136
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR201510001292136 through Pure Global AI's free database. This Not Applicable trial is sponsored by shahira el metainy and is currently Not yet recruiting. The study focuses on Respiratory; Other.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.